CSI Market
Sign In | Register

Vertex Pharmaceuticals Inc (VRTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access VRTX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Vertex Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5,084.80
Marketable Securities, Current SH1,523.30
Cash & Short-term Investments6,607.00
Accounts receivable2,052.80
Inventories1,686.80
Other Current Assets0.00
Prepaid Expense And Other Assets Current853.30
Total Current Assets11,201.00
Goodwill net1,088.00
Intangible Assets424.20
Long-term investments5,712.30
Other Assets, Noncurrent12,929.80
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization1,520.30
Deferred Income Tax Assets Net2,897.90
Operating Lease Right Of Use Asset1,562.70
Total Assets25,643.00
Liabilities
Accounts Payable, Current AC461.70
Accrued Liabilities, Current AC2,971.20
Other Liabilities, Current428.30
Total Current Liabilities3,861.20
Total Long-term Debt0.00
Other liabilities, Noncurrent3,116.00
Finance Lease Liability Noncurrent-
Operating Lease Liability Noncurrent1,846.50
Total Liabilities6,977.20
Stockholders' Equity
Common Stock Value2.50
Additional Paid In Capital Common Stock5,119.20
Retained Earnings / Accumulated Deficit13,560.00
Other Equity-15.90
Common Stockholder's Equity18,665.80
Total Stockholder's Equity18,665.80
Liabilities & Stockholder's Equity25,643.00
4 historic quarters locked

Sign in to unlock the full Vertex Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Vertex Pharmaceuticals Inc Ma Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 13, 2026
  • Source: vrtx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000875320-26-000056

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.